|
Prescription Drug Search
Strengths available for Bicalutamide :
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about MyGlobalPharmacy.com
List of countries where we can ship Bicalutamide:
- Algeria
- Azerbaijan
- Bahrain
- Barbados
- Bulgaria
- China
- Cook Islands
- Costa Rica
- Cuba
- Denmark
- France
- Georgia
- Greece
- Guatemala
- Iceland
- India
- Iraq
- Italy
- Kuwait
- Lebanon
- Moldova, Republic of
- Netherlands
- Norway
- Peru
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Saudi Arabia
- Serbia
- Singapore
- South Africa
- Sri Lanka
- Taiwan
- Tonga
- Turkey
- United Kingdom, UK
- United States, US
- Uzbekistan
Latest news releases on Bicalutamide:
Medivation Files Enzalutamide NDA - Analyst Blog - NASDAQ
Enzalutamide is also in a phase II study (TERRAIN), which will compare enzalutamide with bicalutamide, in advanced prostate cancer patients who have progressed following medical castration with LHRH analog therapy or surgical castration.
Medivation and Astellas Announce Enzalutamide (Formerly MDV3100) Data to Be Presented at ASCO Annual Meeting 2012 - Yahoo Finance
Montgomery, MD General Poster Session: Genitourinary Cancer Location: S Hall A2 (Abstract #TPS4698 / Poster #17A): TERRAIN: A randomized, double-blind, phase II study comparing MDV3100 with bicalutamide (Bic) in men with metastatic castrate ...
MDVN Misses; Focus on Enzalutamide - Yahoo Finance
Enzalutamide is also in a phase II study (TERRAIN), which will compare enzalutamide with bicalutamide, in advanced prostate cancer patients who have progressed following medical castration with LHRH analog therapy or surgical castration.
Medivation Reports First Quarter Financial Results and Provides Corporate Update - Stockhouse
Continued to enroll patients in the Phase 2 TERRAIN trial, which is comparing the effect of enzalutamide versus bicalutamide, the most commonly used anti-androgen, on progression-free survival in approximately 370 men with advanced prostate cancer who have ...
